Neutralization Of Inhibitory Pathways In Lymphocytes
Patent No. EP3799885 (titled "Neutralization Of Inhibitory Pathways In Lymphocytes") was filed by Innate Pharma on Sep 15, 2015. The application was issued on Aug 13, 2025.
Patent Summary
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
EP3799885
- Application Number
- EP20181825A
- Filing Date
- Sep 15, 2015
- Status
- Granted And Under Opposition
- Jul 11, 2025
- Publication Date
- Aug 13, 2025
- External Links
- Slate, Register , Google Patents